FindTrial
Sign In

Transcriptomics analyzes prognostic differences in human drug-refractory epilepsy

Transcriptomics analyzes prognostic differences in human drug-refractory epilepsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085246
Enrollment
Unknown
Registered
2024-06-03
Start date
2022-07-25
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Observation group:Not involving

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Epilepsy patients who seek treatment in our hospital and plan to undergo resection of epileptic lesions (2) Age is less than 80 years old, male or female is not limited (3) The patient or his legal representative agrees to sign an informed consent form

Exclusion criteria

Exclusion criteria: (1) Psychosis or schizophrenia (2) The patient or his legal representative refuses to sign the informed consent form

Design outcomes

Primary

MeasureTime frame
Neuronal Nuclear Antigen;—

Countries

China

Contacts

Public ContactZhen Hong

West China Hospital of Sichuan University

Hongzhengoog@aliyun.com+86 189 8060 5818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026